» Articles » PMID: 177438

The Hormonal Activity of the Postmenopausal Ovary

Overview
Specialty Endocrinology
Date 1976 Feb 1
PMID 177438
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The origin of plasma sex hormones in postmenopausal women was studied by determining plasma levels under basal conditions, after ACTH stimulation, and after dexamethasone suppression, as well as after hCG stimulation. Values obtained in postmenopausal women were compared with values observed during the follicular phase of the cycle in young women on the one hand, and with values in ovariectomized women of postmenopausal age on the other hand. All sex steroid levels studied with the exception of estrone, were significantly lower in postmenopausal women than in young women during the early follicular phase of the cycle. In ovariectomized women only androgen levels (testosterone, androstenedione, dihydrotestosterone, and to a lesser extent dehydroepiandrosterone,) were lower than in normal postmenopausal women, estrogen, 17 hydroxyprogesterone, and progesterone levels being similar. ACTH increased all plasma steroid levels except estradiol, whereas after dexamethasone, all sex hormone levels were significantly decreased. hCG stimulation finally caused an increase of borderline statistical significance in testosterone, dehydroepiandrosterone, and 17-hydroxyprogesterone levels. We have concluded from this study that the adrenal cortex is almost the exclusive source of plasma estradiol, estrone, progesterone, and 17OH progesterone and the most important source of plasma dehydroepiandrosterone; that the postmenopausal ovary appears to be responsible for about 50% of plasma testosterone and 30% of androstenedione levels; and that hCG stimulation with 5000 IU daily for 3 days, hardly influences steroid secretion by postmenopausal ovaries.

Citing Articles

Endogenous sex hormone levels are associated with the revised Framingham Stroke Risk Profile in postmenopausal women: a longitudinal study in a Swedish cohort.

Ottarsdottir K, Tivesten A, Ohlsson C, Li Y, Hellgren M, Lindblad U BMC Endocr Disord. 2025; 25(1):24.

PMID: 39865235 PMC: 11765893. DOI: 10.1186/s12902-025-01841-3.


Impact of ovary-intact menopause in a mouse model of heart failure with preserved ejection fraction.

Troy A, Normukhamedova D, Grothe D, Momen A, Zhou Y, McFadden M Am J Physiol Heart Circ Physiol. 2024; 326(3):H522-H537.

PMID: 38180450 PMC: 11221814. DOI: 10.1152/ajpheart.00733.2023.


Steroid hormone levels and bone mineral density in women over 65 years of age.

Nunes E, Gallardo E, Morgado-Nunes S, Fonseca-Moutinho J Sci Rep. 2023; 13(1):4925.

PMID: 36966199 PMC: 10039944. DOI: 10.1038/s41598-023-32100-x.


Ovarian volume partially explains associations of phthalate biomarkers with anti-Müllerian hormone and estradiol in midlife women.

Cinzori M, Pacyga D, Babayev E, Duncan F, Li Z, Williams P Environ Int. 2023; 172:107771.

PMID: 36724714 PMC: 10012419. DOI: 10.1016/j.envint.2023.107771.


Nocturnal Hot Flashes, but Not Serum Hormone Concentrations, as a Predictor of Insomnia in Menopausal Women: Results from the Midlife Women's Health Study.

Hatcher K, Smith R, Chiang C, Flaws J, Mahoney M J Womens Health (Larchmt). 2022; 32(1):94-101.

PMID: 36450126 PMC: 10024068. DOI: 10.1089/jwh.2021.0502.